Display Settings:

Format

Send to:

Choose Destination
    Neurology. 1992 Feb;42(2):434-6.

    Cognitive functioning in cancer patients: effect of previous treatment.

    Source

    Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

    Abstract

    Neuropsychological analysis of 47 cancer patients with widely metastatic disease and significant previous treatment indicated that 34% had cognitive deficits. Previous treatment with biologic response modifiers was associated with a 53% frequency of cognitive abnormalities, whereas only 18% of patients who were never treated with biologics had such impairments. The possibility that neurobehavioral abnormalities will result from metastatic disease and treatment regimens is an important factor in determining the risks and benefits of therapy.

    PMID:
    1736178
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk